G. Steven Burrill
Chief Executive Officer

Roger E. Wyse
Managing Director

Tania Fernandez
Director - India

The Burrill India Healthcare Capital Fund is being formed to invest in rapidly growing healthcare businesses both within the Indian continent and in ex-India companies that have India as an integral component of their business strategy.

Burrill believes that India is on a long-term high growth path and has uniquely positioned itself to support sustainable high growth opportunities in the life science sector i.e. healthcare and healthcare delivery and maximize value from venture capital/private equity investments in high growth companies. The fund aims to bring near to mid-term value by focusing on companies based on technology infusion, value chain integration, leveraging cost advantages, and driving market expansion both with new and pre-existing businesses.

The Fund intends to build a diversified portfolio of companies, whose technologies, products and services are applicable across the range of healthcare and healthcare delivery sub-sectors: healthcare infrastructure, services and delivery; R&D services; human healthcare therapeutics and diagnostics; stem cells; biogenerics; medical devices; pharmaceutical distribution; Bio-IT; and healthcare delivery.

We also provide a complementary range of services in the cross-border (US-India space) that includes the ability to identify and acquire strategic assets, monetize non-strategic assets through partnering with companies who will share the risk and rewards of developing an asset and access to local capital.


Contact:
Mumbai, India
011 91 981 938 1464
tfernandez@b-c.com